Clinical Trials Browser

Pathologic Complete Response × Oxaliplatin × Gastrointestinal × Clear all

NCT06647680 2026-03-06

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Phase 2 Recruiting

Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT05000697 2024-11-27

CCHOWW

Phase NA Recruiting

Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT01216644 2019-06-19

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Pathologic Complete Response, Stomach Neoplasms